Bismuth-213 is not a cure for lymphoma, but it is being researched as a potential treatment option. It is a radioisotope that can be used in targeted alpha therapy (TAT) to deliver radiation directly to cancer cells, which may improve treatment outcomes for certain types of lymphoma. Clinical trials are ongoing to evaluate its efficacy and safety, but more research is needed before it can be widely accepted as a standard treatment for lymphoma.
Copyright © 2026 eLLeNow.com All Rights Reserved.